Featuring the launch of ChemRxiv, an introduction to open access and an overview of preprint resources.
Featuring data on how much article processing charges cost universities, an overview of transparency tools, the July workstream reports and how authors can push for open science without disadvantaging their careers.
Featuring a study on the state of open access, Elsevier’s shift in strategy with the acquisition of Bepress and a survey of open access resources.
Featuring a look at transparency policies in pharma, Wellcome’s new sharing guidelines and what it means for authors to be in control of peer review
Featuring the importance of net neutrality freedoms for science, the Open Pharma workstream June report and a defence of post-publication peer review. What do threats
Featuring the importance of trust-building for pharma, a study of open access usage patterns and an argument for peer reviewing preprints